194 related articles for article (PubMed ID: 29270012)
1. pH-triggered surface charge-switchable polymer micelles for the co-delivery of paclitaxel/disulfiram and overcoming multidrug resistance in cancer.
Huo Q; Zhu J; Niu Y; Shi H; Gong Y; Li Y; Song H; Liu Y
Int J Nanomedicine; 2017; 12():8631-8647. PubMed ID: 29270012
[TBL] [Abstract][Full Text] [Related]
2. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
[TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
[TBL] [Abstract][Full Text] [Related]
5. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
Zhao D; Zhang H; Yang S; He W; Luan Y
Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331
[TBL] [Abstract][Full Text] [Related]
6. Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram.
Duan X; Xiao J; Yin Q; Zhang Z; Yu H; Mao S; Li Y
ACS Nano; 2013 Jul; 7(7):5858-69. PubMed ID: 23734880
[TBL] [Abstract][Full Text] [Related]
7. A simple reduction-sensitive micelles co-delivery of paclitaxel and dasatinib to overcome tumor multidrug resistance.
Li J; Xu R; Lu X; He J; Jin S
Int J Nanomedicine; 2017; 12():8043-8056. PubMed ID: 29138561
[TBL] [Abstract][Full Text] [Related]
8. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all-
Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q
Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335
[TBL] [Abstract][Full Text] [Related]
9. The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance.
Wan CP; Letchford K; Jackson JK; Burt HM
Int J Nanomedicine; 2013; 8():379-91. PubMed ID: 23378760
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
[TBL] [Abstract][Full Text] [Related]
11. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
12. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously.
Li X; Li P; Zhang Y; Zhou Y; Chen X; Huang Y; Liu Y
Pharm Res; 2010 Aug; 27(8):1498-511. PubMed ID: 20411408
[TBL] [Abstract][Full Text] [Related]
13. PEG-PE-based micelles co-loaded with paclitaxel and cyclosporine A or loaded with paclitaxel and targeted by anticancer antibody overcome drug resistance in cancer cells.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 May; 19(4):169-76. PubMed ID: 22506922
[TBL] [Abstract][Full Text] [Related]
14. Long-circulating PEG-PE micelles co-loaded with paclitaxel and elacridar (GG918) overcome multidrug resistance.
Sarisozen C; Vural I; Levchenko T; Hincal AA; Torchilin VP
Drug Deliv; 2012 Nov; 19(8):363-70. PubMed ID: 23030458
[TBL] [Abstract][Full Text] [Related]
15. Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance.
Lei M; Ma G; Sha S; Wang X; Feng H; Zhu Y; Du X
Drug Deliv; 2019 Dec; 26(1):262-272. PubMed ID: 30856352
[TBL] [Abstract][Full Text] [Related]
16. A dual pH-sensitive liposomal system with charge-reversal and NO generation for overcoming multidrug resistance in cancer.
Chen M; Song F; Liu Y; Tian J; Liu C; Li R; Zhang Q
Nanoscale; 2019 Mar; 11(9):3814-3826. PubMed ID: 30600823
[TBL] [Abstract][Full Text] [Related]
17. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer.
Mohammad IS; Teng C; Chaurasiya B; Yin L; Wu C; He W
Int J Pharm; 2019 Feb; 557():304-313. PubMed ID: 30599232
[TBL] [Abstract][Full Text] [Related]
18. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
19. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin.
Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D
Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
Ji W; Wang B; Fan Q; Xu C; He Y; Chen Y
PLoS One; 2017; 12(7):e0180037. PubMed ID: 28686704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]